GL
Bearish signalScored 2026-09-25 Drivers: Congress, trend, fundamentals. Moteurs : Congrès, tendance, fondamentaux.
Research, not advice.
À propos
Globe Life Inc.
- Nom
- Globe Life Inc.
- Secteur
- Financial Services
- Industrie
- Insurance - Life
- Bourse
- NYSE
- Capitalisation
- $11.9B
- Employés
- 3,695
- PDG
- Frank Martin Svoboda
- Site web
- https://home.globelifeinsurance.com
- Marché
- BHFCNOFGJXNLNCMET
Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 58 258 titres (~10 587 562,09 $ US)
- Insiders
- Darden James MatthewAlston Cheryl
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$3,211,255
Avg sell (VWAP, 90d window) $176.83 vs last close $165.68 (-6.3%)
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-07-31
- Liquidity
- Liquid $71,969,934/day · 20d vol
- Last synced
-
2026-10-20 00:36:23
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-22 | Hensley Robert Edward | Sell · S | 6,656 | $170.34 | $1,133,789 | Form 4 |
| 2026-08-07 | MITCHELL ROBERT BRIAN | Sell · S | 1,017 | $184.75 | $187,892 | Form 4 |
| 2026-07-31 | Darden James Matthew | Sell · S | 400 | $183.36 | $73,343 | Form 4 |
| 2026-07-30 | Kalmbach Thomas Peter | Sell · S | 2,790 | $181.81 | $507,264 | Form 4 |
| 2026-07-29 | MAJORS MICHAEL CLAY | Sell · S | 3,500 | $179.35 | $627,722 | Form 4 |
| 2026-07-28 | Kalmbach Thomas Peter | Sell · S | 3,797 | $179.42 | $681,246 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-01-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-01-13 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-07-10 | Lisa C. McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-06-17 | Lisa C. McClain | Purchase | $1,001 - $15,000 |
| 2023-09-08 | Lois Frankel | Sale (Full) | $1,001 - $15,000 |
| 2023-06-02 | Lois Frankel | Sale (Partial) | $1,001 - $15,000 |
Signal
Bearish signalScored 2026-09-25 Drivers: Congress, trend, fundamentals. Moteurs : Congrès, tendance, fondamentaux.
The 0-100 score behind this signal and the full written analysis are part of Plus. See plans.
Bearish signal
Drivers: Congress, trend, fundamentals. Moteurs : Congrès, tendance, fondamentaux.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. 1 purchase disclosure year to date, a thin reading
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Pulls against a bullish reading. Close is more than 0.5 ATR under stored support
- Financial indicators Supports a bullish reading. Current ratio 9.66 · operating margin 24%
Suggested stop 156.85, nearest stored support minus 0.5 ATR(5.3% under the last close). Reward/risk to the next stored resistance is 0.81. Wait — that reward/risk is under 2. Research, not advice. Not an order.
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 33.4% | 32.4% | 30.1% | 29.5% | 32.9% | |
| Ebit Margin | 26.5% | 25.2% | 23.8% | 22.8% | 26.5% | |
| Ebitda Margin | 26.5% | 25.2% | 23.8% | 22.8% | 26.5% | |
| Operating Profit Margin | 24.4% | 23.0% | 21.9% | 21.1% | 24.9% | |
| Pretax Profit Margin | 24.0% | 23.0% | 21.9% | 21.1% | 24.9% | |
| Continuous Operations Profit Margin | 19.4% | 18.5% | 17.8% | 17.1% | 20.1% | |
| Net Profit Margin | 19.4% | 18.5% | 17.8% | 17.1% | 20.1% | |
| Bottom Line Profit Margin | 19.4% | 18.5% | 17.8% | 17.1% | 20.1% | |
| Current Ratio | 9.662 | 9.482 | 10.831 | 10.665 | 8.155 | |
| Quick Ratio | 9.662 | 9.482 | 10.831 | 10.665 | 8.155 | |
| Solvency Ratio | 0.047 | 0.045 | 0.041 | 0.041 | 0.049 | |
| Cash Ratio | 0.073 | 0.085 | 0.059 | 0.056 | 0.034 | |
| Price To Earnings Ratio | 9.780 | 9.301 | 11.922 | 13.204 | 12.838 | |
| Price To Earnings Growth Ratio | 0.508 | 0.534 | 1.008 | 0.527 | 2.215 | |
| Forward Price To Earnings Growth Ratio | 0.508 | 0.534 | 1.008 | 0.527 | 2.215 | |
| Price To Earnings Diluted Ratio | 9.947 | 9.340 | 12.087 | 13.335 | 12.981 | |
| Price To Earnings Diluted Growth Ratio | 0.560 | 0.503 | 1.061 | 0.529 | 2.213 | |
| Price To Book Ratio | 1.893 | 1.765 | 2.579 | 2.989 | 1.107 | |
| Price To Sales Ratio | 1.885 | 1.620 | 2.124 | 2.259 | 1.868 | |
| Price To Free Cash Flow Ratio | 9.018 | 7.031 | 8.077 | 8.467 | 6.836 | |
| Price To Operating Cash Flow Ratio | 8.098 | 6.675 | 7.807 | 8.301 | 6.654 | |
| Debt To Assets Ratio | 0.085 | 0.094 | 0.075 | 0.080 | 0.068 | |
| Debt To Equity Ratio | 0.439 | 0.516 | 0.472 | 0.526 | 0.234 | |
| Debt To Capital Ratio | 0.305 | 0.341 | 0.320 | 0.345 | 0.190 | |
| Long Term Debt To Capital Ratio | 0.280 | 0.305 | 0.266 | 0.292 | 0.152 | |
| Financial Leverage Ratio | 5.157 | 5.480 | 6.252 | 6.580 | 3.444 | |
| Working Capital Turnover Ratio | 0.358 | 0.344 | 0.329 | 0.295 | 0.526 | |
| Operating Cash Flow Ratio | 0.707 | 0.724 | 0.847 | 0.864 | 0.528 | |
| Operating Cash Flow Sales Ratio | 0.233 | 0.243 | 0.272 | 0.272 | 0.281 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.898 | 0.949 | 0.967 | 0.980 | 0.973 | |
| Debt Service Coverage Ratio | 2.945 | 2.208 | 1.824 | 1.825 | 1.979 | |
| Interest Coverage Ratio | 10.358 | 10.438 | 11.672 | 12.192 | 15.267 | |
| Short Term Operating Cash Flow Coverage Ratio | 4.584 | 3.376 | 3.050 | 3.167 | 2.997 | |
| Operating Cash Flow Coverage Ratio | 0.532 | 0.512 | 0.701 | 0.685 | 0.710 | |
| Capital Expenditure Coverage Ratio | 9.800 | 19.740 | 29.916 | 50.922 | 37.592 | |
| Dividend Paid And Capex Coverage Ratio | 6.110 | 8.960 | 11.090 | 13.111 | 12.154 | |
| Dividend Payout Ratio | 0.074 | 0.080 | 0.087 | 0.090 | 0.078 | |
| Enterprise Value Multiple | 8.662 | 8.211 | 10.478 | 11.564 | 8.468 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 33.4% | ▲1.0% | ▲1.7% |
| Ebit Margin | 26.5% | ▲1.4% | ▲1.6% |
| Ebitda Margin | 26.5% | ▲1.4% | ▲1.6% |
| Operating Profit Margin | 24.4% | ▲1.4% | ▲1.3% |
| Pretax Profit Margin | 24.0% | ▲1.0% | ▲1.0% |
| Continuous Operations Profit Margin | 19.4% | ▲0.8% | ▲0.8% |
| Net Profit Margin | 19.4% | ▲0.8% | ▲0.8% |
| Bottom Line Profit Margin | 19.4% | ▲0.8% | ▲0.8% |
| Current Ratio | 9.662 | ▲0.180 | ▼-0.097 |
| Quick Ratio | 9.662 | ▲0.180 | ▼-0.097 |
| Solvency Ratio | 0.047 | ▲0.002 | ▲0.002 |
| Cash Ratio | 0.073 | ▼-0.012 | ▲0.012 |
| Price To Earnings Ratio | 9.780 | ▲0.479 | ▼-1.629 |
| Price To Earnings Growth Ratio | 0.508 | ▼-0.026 | ▼-0.450 |
| Forward Price To Earnings Growth Ratio | 0.508 | ▼-0.026 | ▼-0.450 |
| Price To Earnings Diluted Ratio | 9.947 | ▲0.607 | ▼-1.591 |
| Price To Earnings Diluted Growth Ratio | 0.560 | ▲0.057 | ▼-0.413 |
| Price To Book Ratio | 1.893 | ▲0.128 | ▼-0.174 |
| Price To Sales Ratio | 1.885 | ▲0.265 | ▼-0.066 |
| Price To Free Cash Flow Ratio | 9.018 | ▲1.987 | ▲1.132 |
| Price To Operating Cash Flow Ratio | 8.098 | ▲1.423 | ▲0.591 |
| Debt To Assets Ratio | 0.085 | ▼-0.009 | ▲0.005 |
| Debt To Equity Ratio | 0.439 | ▼-0.077 | ▲0.002 |
| Debt To Capital Ratio | 0.305 | ▼-0.035 | ▲0.005 |
| Long Term Debt To Capital Ratio | 0.280 | ▼-0.025 | ▲0.021 |
| Financial Leverage Ratio | 5.157 | ▼-0.323 | ▼-0.225 |
| Working Capital Turnover Ratio | 0.358 | ▲0.014 | ▼-0.013 |
| Operating Cash Flow Ratio | 0.707 | ▼-0.017 | ▼-0.027 |
| Operating Cash Flow Sales Ratio | 0.233 | ▼-0.010 | ▼-0.027 |
| Free Cash Flow Operating Cash Flow Ratio | 0.898 | ▼-0.051 | ▼-0.056 |
| Debt Service Coverage Ratio | 2.945 | ▲0.737 | ▲0.789 |
| Interest Coverage Ratio | 10.358 | ▼-0.081 | ▼-1.628 |
| Short Term Operating Cash Flow Coverage Ratio | 4.583 | ▲1.207 | ▲1.149 |
| Operating Cash Flow Coverage Ratio | 0.532 | ▲0.020 | ▼-0.096 |
| Capital Expenditure Coverage Ratio | 9.800 | ▼-9.940 | ▼-19.794 |
| Dividend Paid And Capex Coverage Ratio | 6.110 | ▼-2.850 | ▼-4.175 |
| Dividend Payout Ratio | 0.074 | ▼-0.006 | ▼-0.007 |
| Enterprise Value Multiple | 8.662 | ▲0.452 | ▼-0.814 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $11.31B | $9.36B | $11.57B | $11.81B | $9.57B | |
| Enterprise value | $13.79B | $11.94B | $13.59B | $13.79B | $11.50B | |
| EV / Sales | 2.30x | 2.07x | 2.49x | 2.64x | 2.25x | |
| EV / Op. cash flow | 9.87x | 8.51x | 9.16x | 9.70x | 8.00x | |
| EV / Free cash flow | 11.00x | 8.96x | 9.48x | 9.89x | 8.22x | |
| EV / EBITDA | 8.66x | 8.21x | 10.48x | 11.56x | 8.47x | |
| Net debt / EBITDA | 1.56x | 1.77x | 1.55x | 1.66x | 1.42x | |
| Current ratio | 9.66x | 9.48x | 10.83x | 10.66x | 8.15x | |
| Income quality | 1.20x | 1.31x | 1.53x | 1.59x | 1.93x | |
| Graham number | $155 | $135 | $104 | $91 | $139 | |
| Graham net-net | -$74 | -$67 | -$51 | -$48 | $9 | |
| Tax burden | 80.7% | 80.7% | 81.3% | 81.2% | 80.9% | |
| Interest burden | 90.4% | 91.3% | 92.1% | 92.4% | 93.9% | |
| Working capital | $17.11B | $16.43B | $17.21B | $15.91B | $19.48B | |
| Invested capital | $24.97B | $23.70B | $23.94B | $22.14B | $25.08B | |
| Return on assets | 3.8% | 3.7% | 3.5% | 3.4% | 3.5% | |
| Operating ROA | 4.9% | 4.6% | 4.4% | 4.0% | 4.3% | |
| Return on tangible assets | 5.0% | 4.8% | 4.5% | 4.5% | 4.2% | |
| Return on equity | 19.4% | 20.2% | 21.6% | 22.6% | 11.9% | |
| Return on invested capital | 4.0% | 3.9% | 3.6% | 3.6% | 3.7% | |
| Return on capital employed | 5.1% | 4.9% | 4.5% | 4.5% | 4.7% | |
| Earnings yield | 10.3% | 11.4% | 8.4% | 7.6% | 10.8% | |
| Free cash flow yield | 11.1% | 14.2% | 12.4% | 11.8% | 14.6% | |
| Capex / Op. cash flow | 10.2% | 5.1% | 3.3% | 2.0% | 2.7% | |
| Capex / Depreciation | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Capex / Sales | 2.4% | 1.2% | 0.9% | 0.5% | 0.7% | |
| SG&A / Sales | 3.3% | 6.6% | 6.1% | 6.4% | 5.9% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Intangibles / Total assets | 24.3% | 24.0% | 23.1% | 23.2% | 18.1% | |
| Days sales outstanding | 63d | 61d | 60d | 59d | 53d | |
| Days payables outstanding | 49d | 50d | 49d | 50d | 44d | |
| Operating cycle | 63d | 61d | 60d | 59d | 53d | |
| Cash conversion cycle | 14d | 11d | 11d | 9d | 9d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+20.8%EV / Sales ▲+11.3%EV / EBITDA ▲+5.5%EV / Op. cash flow ▲+1.364Earnings yield ▼-0.012Graham number ▲+19.847
Profitability
Return on equity ▼-0.007Return on assets ▲+0.001Return on invested capital ▲+0.002Return on capital employed ▲+0.002Operating ROA ▲+0.002Income quality ▼-0.107Tax burden ▼-0.001
Efficiency
Days sales outstanding ▲+2.617Days payables outstanding ▼-0.354Operating cycle ▲+2.617Cash conversion cycle ▲+2.971Capex / Sales ▲+0.011R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.180Net debt / EBITDA ▼-0.212Working capital ▲+684437000.000Invested capital ▲+1272984000.000Intangibles / Total assets ▲+0.003
Change over 5 years
Valuation
Market cap ▲+18.2%EV / Sales ▲+2.4%EV / EBITDA ▲+2.3%EV / Op. cash flow ▲+1.875Earnings yield ▼-0.005Graham number ▲+15.796
Profitability
Return on equity ▲+0.075Return on assets ▲+0.003Return on invested capital ▲+0.003Return on capital employed ▲+0.004Operating ROA ▲+0.006Income quality ▼-0.727Tax burden ▼-0.002
Efficiency
Days sales outstanding ▲+10.716Days payables outstanding ▲+5.527Operating cycle ▲+10.716Cash conversion cycle ▲+5.189Capex / Sales ▲+0.016R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+1.508Net debt / EBITDA ▲+0.134Working capital ▼-2367880000.000Invested capital ▼-109817000.000Intangibles / Total assets ▲+0.062
Employee count
Peer market caps
Recent news
- 2026-10-19 What''s in the Cards for Globe Life This Earnings Season? GL expects stronger life and health underwriting margins, higher investment income and share buybacks to support third-quarter results.
- 2026-10-19 Globe Life Inc. Announces Third Quarter 2026 Earnings Release and Conference Call Globe Life Inc. Announces Third Quarter 2026 Earnings Release and Conference CallPR NewswireMCKINNEY, Texas, Oct. 19, 2026MCKINNEY, Texas, Oct. 19, 2026 /PRNews
- 2026-10-16 Head to Head Analysis: eHealth (NASDAQ:EHTH) & Globe Life (NYSE:GL) Globe Life (NYSE: GL - Get Free Report) and eHealth (NASDAQ: EHTH - Get Free Report) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Analyst Recommendations This is a summary of current ratings
- 2026-10-14 Globe Life (GL) Earnings Expected to Grow: Should You Buy? Globe Life (GL) doesn''t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 2026-10-07 Globe Life Inc. Announces Third Quarter 2026 Earnings Release and Conference Call MCKINNEY, Texas, Oct. 7, 2026 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) will announce its Third Quarter 2026 financial results after the market closes on Wednesday, October 21, 2026. At that time, a copy of the Company''s Third Quarter 2026 earnings press release and any other financial and statistical information about the quarter will be available on the Company''s website, https://investors.globelifeinsurance.com, under Financial Reports and Other Financial Information.
- 2026-10-01 Globe Life: Discounted Valuation, Growing Dividends, And Aggressive Buybacks Globe Life Inc. demonstrates consistent earnings growth, robust buybacks, and disciplined dividend increases, targeting underserved middle-income markets. GL''s Q2 2026 net operating income per share rose 10.4% year-over-year, with a 14.3% ROE and aggressive share repurchases below fair value. A new $2.5 billion buyback authorization and a secure, fast-growing dividend (10–12% annually) underpin a compelling long-term total return profile.
- 2026-09-24 Globe Life''s Health Premium Growth Strengthens 2026 Outlook GL''s health business is accelerating premium growth, led by United American and Family Heritage, while adding diversification beyond life insurance.
- 2026-09-24 Globe Life (NYSE:GL) EVP Robert Edward Hensley Sells 10,000 Shares of Stock Globe Life Inc. (NYSE: GL - Get Free Report) EVP Robert Hensley sold 10,000 shares of the business''s stock in a transaction that occurred on Tuesday, September 22nd. The shares were sold at an average price of $170.07, for a total value of $1,700,700.00. Following the completion of the transaction, the executive vice president owned 12,384
- 2026-09-24 State Street Corp Buys 76,745 Shares of Globe Life Inc. $GL State Street Corp increased its position in Globe Life Inc. (NYSE: GL) by 2.1% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,735,409 shares of the company''s stock after purchasing an additional 76,745 shares during the quarter. State Street
- 2026-09-18 GL Outperforms Industry, Trades at a Discount: How to Play the Stock Globe Life expects premium growth, AI adoption and distribution expansion to support earnings, while strong capital enables substantial share buybacks.